Globen provides ophthalmology treatments at two locations in the southern part of Stockholm and performs annually about 36,000 consultations and 4,600 surgeries. The clinic serves both public and private pay patients, with its main focus being on supporting the public healthcare system (about 80% of net sales are publicly financed). The acquisition follows the acquisition of Scanloc (Sweden) in August 2016 and Capio’s recent acquisition of Augenklinik Universitätsallee (Germany), and further strengthens Capio’s healthcare offering within ophthalmology and expands the Group’s footprint in the Nordics.
Globen will be included in Capio Medocular, which is part of the business area Capio Specialist Clinics. Capio Medocular was founded in 1986 and is today one of the largest private companies within ophthalmology treatments in the Nordics, specialized in general eye care, cataract surgery and treatment of sight disorders.
Enterprise value is MSEK 75 and the acquisition, which is subject to approval by the county council (SLL), is expected to be closed and included in Capio from May 31, 2017. The acquisition is not expected to significantly impact the Group’s earnings in 2017.
For information, please contact:
Olof Bengtsson, CFO
Telephone: +46 761 18 74 69
Kristina Ekeblad, IR manager
Telephone: +46 708 31 19 40